4/23
07:04 am
alny
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 [Yahoo! Finance]
Low
Report
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 [Yahoo! Finance]
4/21
02:04 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/18
11:47 am
alny
Gene Therapy: Non-Viral Vectors [Forbes]
Low
Report
Gene Therapy: Non-Viral Vectors [Forbes]
4/18
08:00 am
alny
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Low
Report
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
4/18
07:25 am
alny
ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc.
Low
Report
ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc.
4/17
07:25 am
alny
Levi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNY
Low
Report
Levi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNY
4/13
02:04 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/11
07:20 am
alny
Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY
Low
Report
Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY
4/10
12:05 pm
alny
Wolfe upgrades Ionis to outperform, cites upcoming catalysts [Seeking Alpha]
Low
Report
Wolfe upgrades Ionis to outperform, cites upcoming catalysts [Seeking Alpha]
4/10
07:25 am
alny
ALNY STOCK ALERT: Levi & Korsinsky Notifies Alnylam Pharmaceuticals, Inc. Investors of an Ongoing Investigation
Low
Report
ALNY STOCK ALERT: Levi & Korsinsky Notifies Alnylam Pharmaceuticals, Inc. Investors of an Ongoing Investigation
4/9
07:30 am
alny
Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY
Low
Report
Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY
4/8
11:23 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
4/8
07:20 am
alny
Did Alnylam Pharmaceuticals, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ALNY
Low
Report
Did Alnylam Pharmaceuticals, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ALNY
4/7
08:08 am
alny
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension [Yahoo! Finance]
Low
Report
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension [Yahoo! Finance]
4/7
08:00 am
alny
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
Low
Report
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
4/5
11:02 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/29
07:44 am
alny
Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63% [Yahoo! Finance]
Low
Report
Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63% [Yahoo! Finance]
3/29
07:20 am
alny
Levi & Korsinsky Announces an Investigation on Behalf of Alnylam Pharmaceuticals, Inc. (ALNY) Shareholders Who May Have Been Affected by Fraud
Low
Report
Levi & Korsinsky Announces an Investigation on Behalf of Alnylam Pharmaceuticals, Inc. (ALNY) Shareholders Who May Have Been Affected by Fraud
3/28
07:30 am
alny
Investors who lost money on Alnylam Pharmaceuticals, Inc. should contact Levi & Korsinsky about an ongoing investigation - ALNY
Medium
Report
Investors who lost money on Alnylam Pharmaceuticals, Inc. should contact Levi & Korsinsky about an ongoing investigation - ALNY
3/27
10:08 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
3/26
04:18 pm
alny
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress [Yahoo! Finance]
Low
Report
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress [Yahoo! Finance]
3/26
07:20 am
alny
Alnylam Being Investigated on Behalf of Alnylam Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details.
Low
Report
Alnylam Being Investigated on Behalf of Alnylam Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details.
3/25
07:30 am
alny
Lost Money on Alnylam Pharmaceuticals, Inc.(ALNY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Low
Report
Lost Money on Alnylam Pharmaceuticals, Inc.(ALNY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
3/22
11:03 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/22
07:20 am
alny
Alnylam Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- ALNY
Low
Report
Alnylam Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- ALNY